Answers are grounded in this paper and cite their sources.
Diagnostic assay evaluation demonstrates ultrasensitive visual detection of exosomes in clinical samples, indicating strong potential for point-of-care cancer diagnostics.
. Second, streptavidin-HRP complex-modified gold nanoparticles (GNPs-Str-HRP) as a signal amplification probe was introduced to further enhance the detection signal by binding to Bio-TR. Lastly, the addition of 3,3',5,5'-tetramethylbenzidine (TMB) solution induced a visible color change, enabling quantification of the exosome concentration. This dual-signal amplification strategy resulted in a low limit of detection (LOD) of 63 particles per μL, and it also demonstrated accurate visual diagnosis capabilities for clinical samples. The successful implementation of this approach suggests its potential as a promising tool for point-of-care testing (POCT) in cancer diagnostics.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: